ABSI Stock Analysis: Buy, Sell, or Hold?
ABSI - Absci Corporation Common Stock
$8.40
0.99 (13.36%)
▲
5d:
+23.53%
30d:
+69.7%
90d:
+183.78%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ABSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ABSI is 17.3% above its trading range ($7.16). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ABSI is 17.3% above its trading range ($7.16). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ABSI is currently trading at $8.40, which is considered extended relative to its 30-day fair value range of $5.26 to $7.16.
Technical Outlook: Technically, ABSI is in a strong uptrend. The price is approaching resistance at $8.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 13.4% recently.
Market Sentiment: ABSI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.61 (+14.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABSI is in a strong uptrend. The price is approaching resistance at $8.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 13.4% recently.
Market Sentiment: ABSI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.61 (+14.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.26 -
$7.16
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BEARISH: Price significantly overextended (+17.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.4%)
- BULLISH: Trading below Wall St target ($9.61)
- WARNING: Recommendation downgraded due to 17.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$5.26 -
$7.16
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.07
Resistance Level
$8.57
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.05
Wall Street Target
$9.61
(+14.4%)
Revenue Growth (YoY)
-81.8%
Share & Embed Analysis
Last updated: June 23, 2026 8:44 AM ET
Data refreshes hourly during market hours. Next update: 9:44 AM
Data refreshes hourly during market hours. Next update: 9:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABSI showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Andreas Busch
BUY
100000 shares
2026-03-12
Sean Mcclain
SELL
26761 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 64 BUY |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
